Print Page   |   Contact Us   |   Your Cart   |   Report Abuse   |   Sign In   |   Apply for NAQC Membership
Site Search

Sign up for NAQC membership today!

Receive a monthly issue of Connections!
NAQC Newsroom: Announcements

Final FY19 Appropriations Bill

Friday, September 14, 2018  
Posted by: Natalia Gromov

Last night, Congress released the bipartisan conference report for the FY19 Defense and Labor, Health and Human Services and Education (LHHS) appropriations bill to provide funding for health agencies for the entire FY19, which begins on Oct. 1.


Important public health provisions in the bill include:

  • CDC: $7.9 billion and, after accounting for one-time facilities funding in FY18, the legislation provides an increase of $126 million from FY18 for CDC on a comparable funding level. The bill also includes $805 million in transfers from the Prevention and Public Health Fund. The bill creates a $50 million infectious disease rapid response fund, where funds only become available for use in the event of a public health emergency. In addition to these provisions, the FY19 LHHS bill includes $10 million to continue efforts to track children and families affected by the Zika virus and $5 million to address infectious diseases related to the opioid crisis.
  • HRSA: $6.8 billion, a $107 million increase from FY18. This funding includes $678 million, a $26 million increase for the Title V Maternal and Child Health block grant and $122.5 million, an increase of $12 million for the Healthy Start program.
  • SAMHSA: $5.7 billion, a $584 million increase from FY18. The legislation maintains a prohibition on federal funds for the purchase of syringes or sterile needles, but allows communities with rapid increases in cases of HIV and hepatitis to access federal funds for other activities, including substance use counseling and treatment referrals. This funding also includes $1.5 billion for the state opioid response grants.

Read the bill’s text here, the committee report here, and a summary here.


ASTHO’s detailed summary and analysis can be found here.


Regarding the proposed move of the strategic national stockpile (SNS) from CDC to ASPR, the conference report does not shift the funding from CDC to ASPR and Congress included the report language below. ASTHO received confirmation that keeping the funding at CDC will not impact the transfer of SNS to ASPR, but Congress will be monitoring these developments closely.


Report Language on the Strategic National Stockpile (SNS): The conferees direct the Secretary to ensure that the administrative transition of the SNS from CDC to ASPR covers any programmatic or funding gaps that would hinder CDC's ability to continue their ongoing activities related to the SNS or any other ongoing activity. The conferees reiterate that the Secretary is directed to maintain a strong and central role for CDC in the medical countermeasures enterprise.


Outlook: The Senate is expected to consider the bill next week and ASTHO anticipates it will be approved by a bipartisan vote. The legislation then moves to the House where it faces a less certain future. We expect this legislation will need to garner both democrat and republican votes to move the bill to the President’s desk for his signature.


If you have any questions or concerns, please contact Carolyn Mullen, ASTHO’s chief of government affairs and public relations.

Sign In

Latest News


       Membership 11 years!.

    3219 E. Camelback Road, #416, Phoenix, AZ 85018 | Ph: 800.398.5489 | Fax: 800.398.5489 |